Toby Maher MD MSc PhD

Toby Maher is Professor of Medicine and Director of Interstitial Lung Disease at Keck School of Medicine, University of Southern California, Los Angeles.

Dr Maher has spent the last 20 years specialising in the management of all forms of pulmonary fibrosis and orphan interstitial lung diseases. He previously ran the ILD unit at Royal Brompton Hospital, London. Since June 2020 he has been Director of ILD at Keck Medicine of University of Southern California in Los Angeles. His research interests include; biomarker discovery, the lung microbiome and host immune response in the pathogenesis of IPF and clinical trials in interstitial lung disease. He has been involved in >100 trials in fibrotic lung disease from phase 1b through to phase 4 and including those assessing IPF, sarcoidosis, scleroderma, rheumatoid arthritis and inflammatory myositis. He is an associate editor for American Journal of Respiratory and Critical Care Medicine and is on the Editorial Board of Lancet Respiratory Medicine. He has authored over 400 papers and book chapters on pulmonary fibrosis.